News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Actelion Ltd. Shares Jump On New Takeover Talk; Traders Speculating GlaxoSmithKline Could Make Offer
October 14, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH, Oct 14 (Reuters) - Shares in Actelion Ltd jumped again on Thursday on new market talk the Swiss biotech group could be the next bid target in the pharmaceuticals sector, bringing their gains this month to almost a third.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
GlaxoSmithKline
MORE ON THIS TOPIC
Neuroscience
Servier Bets $450M On Kaerus’ Fragile X Syndrome Therapy
September 8, 2025
·
2 min read
·
Tristan Manalac
IPO
SPACs Line Up To Clear Biotech’s IPO Backlog
September 3, 2025
·
6 min read
·
Annalee Armstrong
IPO
After Short Stint as a Private Company, BBOT Leaves SPAC Process Ready To Execute
September 3, 2025
·
3 min read
·
Annalee Armstrong
Deals
Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact
September 2, 2025
·
2 min read
·
Heather McKenzie